Kynurenine and its metabolites-kynurenic acid and anthranilic acid are associated with soluble endothelial adhesion molecules and oxidative status in patients with chronic kidney disease

American Journal of the Medical Sciences

Volumn 338, Issue 4, 2009, Pages 293-300

  Pawlak, Krystyna ^a   Kowalewska, Anna ^a   Mysliwiec, Michal ^a   Pawlak, Dariusz ^a,b  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^b UNIVERSITY OF WARMIA AND MAZURY IN OLSZTYN   (Poland)

Author keywords

Anthranilic acid; Chronic kidney disease; Kynurenic acid; Oxidative stress; Soluble adhesion molecules

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANTHRANILIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; CALCIUM CHANNEL BLOCKING AGENT; CELL ADHESION MOLECULE; COPPER ZINC SUPEROXIDE DISMUTASE; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; ERYTHROPOIETIN; INTERCELLULAR ADHESION MOLECULE 1; KYNURENIC ACID; KYNURENINE; NITRATE; PADGEM PROTEIN; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; ANEMIA; ARTICLE; BLOOD SAMPLING; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMODIALYSIS; HUMAN; INFLAMMATION; KIDNEY FAILURE; KIDNEY FUNCTION; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; THROMBOCYTE; TREATMENT DURATION;

EID: 70350141530     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/MAJ.0b013e3181aa30e6     Document Type: Article

References (34)

1. Zoccali C, Mallamaci F, Tripepi G. Traditional and emerging cardiovascular risk factors in end-stage renal disease. Kidney Int 2003;85: S105-10.
2. Stenvinkel P, Pecoits-Filho R, Lindholm B. Coronary artery disease in end-stage renal disease: no longer a simple plumbing problem. J Am Soc Nephrol 2003;14:1927-1939.
3. Blankenberg S, Barbaux S, Tiret L. Adhesion molecules and atherosclerosis. Atherosclerosis 2003;170:191-203.
4. Frijns CJ, Kappelle LJ, van Gijn J, et al. Soluble adhesion molecules reflect endothelial cell activation in ischemic stroke and in carotid atherosclerosis. Stroke 1997;28:2214-2218
5. Pigott R, Dillon LP, Hemingway IH, et al. Soluble forms of ETABLE selectin, ICAM-1 and VCAM-1 are present in the supernatant of cytokine activated cultured endothelial cells. Biochem Biophys Res Commun 1992;187:584-589
6. Stone TW. Neuropharmacology of quinolinic and kynurenic acids. Pharmacol Rev 1993;45:309-379
7. Stone TW. Kynurenines in the CNS: from endogenous obscurity to therapeutic importance. Prog Neurobiol 2001;64:185-218.
8. Dale WE, Dang Y, Amiridze N, et al. Evidence that kynurenine pathway metabolites mediate hyperbaric oxygen-induced convulsions. Toxicol Lett 2000;117:37-43.
9. Pawlak D, Tankiewicz A, Mysliwiec P, et al. Tryptophan metabolism via the kynurenine pathway in experimental chronic renal failure. Nephron 2002;90:328-335
10. Pawlak D, Tankiewicz A, Buczko W. Kynurenine and its metabolites in the rat with experimental renal insufficiency. J Physiol Pharmacol 2001;52:755-766
11. Tankiewicz A, Pawlak D, Pawlak K, et al. Anthranilic acid-uraemic toxin damaged red cell's membrane. Int Urol Nephrol 2005;37:621-627
12. Pawlak D, Pawlak K, Malyszko J, et al. Accumulation of toxic products degradation of kynurenine in hemodialyzed patients. Int Urol Nephrol 2001;33:399-404.
13. Stazka J, Luchowski P, Wielosz M, et al. Endothelium-dependent production and liberation of kynurenic acid by rat aortic rings exposed to L-kynurenine. Eur J Pharmacol 2002;448:133-137
14. Schroecksnadel K, Frick B, Winkler C, et al. Crucial role of interferon- and stimulated macrophages in cardiovascular disease. Curr Vasc Pharmacol 2006;4:205-213
15. Pawlak K, Domaniewski T, Mysliwiec M, et al. The kynurenines are associated with oxidative stress, inflammation and the prevalence of cardiovascular disease in patients with end-stage renal disease. Atherosclerosis 2009;204:309-314
16. Gearing AJ, Newman W. Circulating adhesion molecules in disease. Immunol Today 1993;14:506-512
17. Stenvinkel P, Lindholm B, Heimburger M, et al. Elevated serum levels of soluble adhesion molecules predict death in pre-dialysis patients: association with malnutrition, inflammation, and cardiovascular disease. Nephrol Dial Transplant 2000;15:1624-1630
18. Papagianni A, Dovas S, Bantis C, et al. Carotid atherosclerosis and endothelial cell adhesion molecules as predictors of long-term outcome in chronic hemodialysis patients. Am J Nephrol 2008;28:265-274
19. Papagianni A, Kokolina E, Kalovoulos M, et al. Carotid atherosclerosis is associated with inflammation, malnutrition and intercellular adhesion molecule-1 in patients on continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant 2004;19:1258-1263
20. Papagianni A, Kalovoulos M, Kirmizis D, et al. Carotid atherosclerosis is associated with inflammation and endothelial cell adhesion molecules in chronic haemodialysis patients. Nephrol Dial Transplant 2003;18:113-119
21. Pawlak K, Pawlak D, Mysliwiec M. Cu/Zn SOD plasma levels as a new useful clinical biomarker of oxidative stress in patients with end-stage renal disease. Clin Biochem 2005;38:700-705
22. National Kidney Fundation. K/DOQI clinical practice guidelines for chronic kidney disease evaluation, classification, and stratification. Am J Kidney Dis 2002;39:S76 -92.
23. Schefold JC, Zeden JP, Fotopoulou C, et al. Increased IDO activity and elevated serum levels of tryptophan catabolites in patients with chronic kidney disease: a possible link between chronic inflammation and uraemic symptoms. Nephrol Dial Transplant 2009;24:1901-1908
24. Cristol JP, Canaud B, Rabesandratana H, et al. Enhancement of reactive oxygen species production and cell surface markers expression due to haemodialysis. Nephrol Dial Transplant 1994;9:389-394
25. Nagai T, Kuryiama M, Kawada Y. Oxidative metabolism of polymorphonuclear leukocytes in continuous peritoneal dialysis. Perit Dial Int 1997;17:167-174
26. Okuda S, Nishiyama N, Saito H, et al. Hydrogen peroxide-mediated neuronal cell death induced by endogenous neurotoxin, 3-hydroxykynurenine. Proc Nat Acad Sci USA 1996;93:12553-12558
27. Santamaria A, Flores-Escartin A, Martinez JC, et al. Copper blocks quinolinic acid neurotoxicity in rats: contribution of antioxidant systems. Free Radic Biol Med 2003;35:418-427
28. Hirata F, Hayaishi O. Studies on indoleamine 2,3-dioxygenase. I. Superoxide anion as substrate. J Biol Chem 1975;250:5960-5966
29. Malyszko J, Malyszko JS, Mysliwiec M. Endothelial cell injury markers in chronic renal failure on conservative treatment and continuous ambulatory peritoneal dialysis. Kidney Blood Press Res 2004;27: 71-77
30. Marui N, Offermann MK, Swerlick R, et al. Vascular cell adhesion molecule-1 (VCAM-1) gene transcription and expression are regulated through an antioxidant-sensitive mechanism in human vascular endothelial cells. J Clin Invest 1993;92:1866 -1874.
31. Erel O, Vural H, Aksoy N, et al. Oxidative stress of platelets and thrombocytopenia in patients with vivax malaria. Clin Biochem 2001; 34:341-344
32. Gearing AJ, Hemingway I, Pigott R, et al. Soluble forms of vascular adhesion molecules: E-selectin, ICAM-1 and VCAM-1: pathological significance. Ann NY Acad Sci 1992;667:324-331
33. Li H, Cybulsky MI, Gimbrone MA, et al. An atherogenic diet rapidly induces VCAM-1, a cytokine-regulatable mononuclear leukocyte adhesion molecule, in rabbit aortic endothelium. Arterioscler Thromb 1993;13:197-204.
34. Schnabel R, Blankenberg S. Oxidative stress in cardiovascular disease. Successful translation from bench to bedside? Circulation 2007; 116:1338-1340